Latest News and Press Releases

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Prostate Care Market (2025 Edition): Analysis By Treatment Type (Medications, Surgical Treatments, Minimally Invasive Therapies, and Radiation...

Prodeon Medical completes patient enrollment for the Expander-2 Trial, a study evaluating the Urocross Expander System for LUTS due to BPH.

Wilmington, Delaware, United States, Transparency Market Research. Inc. , July 08, 2024 (GLOBE NEWSWIRE) -- The prostate health market (Markt für Prostatagesundheit) was projected to attain US$ 31.9...

CINCINNATI, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the “Company”) today issued the following shareholder letter from the Company’s Chief Executive Officer...

Rockville, Aug. 14, 2023 (GLOBE NEWSWIRE) -- According to the new market research report, titled, "Insulin Pumps Market By Type (Tethered Pumps, Patch Pumps), By Accessory (Infusion Set Insertion...

CINCINNATI, July 25, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and...

LOS ANGELES, July 20, 2023 (GLOBE NEWSWIRE) -- The Benign Prostatic Hyperplasia Therapeutics Market is witnessing significant growth due to the increasing prevalence of BPH and the rising demand for...

CINCINNATI, July 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and...

New York, USA, July 13, 2023 (GLOBE NEWSWIRE) -- Benign Prostatic Hyperplasia Treatment Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Benign...

CINCINNATI, July 11, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and...